Published in Leukemia on July 26, 2007
miR-19 is a key oncogenic component of mir-17-92. Genes Dev (2009) 4.95
PTEN-deficient cancers depend on PIK3CB. Proc Natl Acad Sci U S A (2008) 3.87
Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers. Proc Natl Acad Sci U S A (2010) 2.67
B-cell receptor signaling as a driver of lymphoma development and evolution. Semin Cancer Biol (2013) 1.39
Oncogenic mutations of PIK3CA in human cancers. Curr Top Microbiol Immunol (2010) 1.27
Quantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphoma. Am J Pathol (2012) 1.20
Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations. Oncogene (2010) 1.16
PIK3CA alterations in Middle Eastern ovarian cancers. Mol Cancer (2009) 1.11
Molecular pathogenesis of diffuse large B-cell lymphoma. Semin Diagn Pathol (2011) 1.11
Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases. J Exp Med (2010) 1.10
Both p110α and p110β isoforms of PI3K can modulate the impact of loss-of-function of the PTEN tumour suppressor. Biochem J (2012) 1.03
Glucose metabolism measured by [¹⁸F]fluorodeoxyglucose positron emission tomography is independent of PTEN/AKT status in human colon carcinoma cells. Transl Oncol (2011) 0.98
Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer. J Cancer Res Clin Oncol (2014) 0.96
The phosphoinositide 3-kinase signaling pathway in normal and malignant B cells: activation mechanisms, regulation and impact on cellular functions. Front Immunol (2012) 0.95
PI3K/mTOR inhibition markedly potentiates HDAC inhibitor activity in NHL cells through BIM- and MCL-1-dependent mechanisms in vitro and in vivo. Clin Cancer Res (2014) 0.94
Status of PI3K/Akt/mTOR pathway inhibitors in lymphoma. Clin Lymphoma Myeloma Leuk (2014) 0.88
Targeting the phosphoinositide 3-kinase pathway in hematologic malignancies. Haematologica (2014) 0.87
Targeting mTOR for the treatment of B cell malignancies. Br J Clin Pharmacol (2016) 0.85
The Role of mTOR Inhibitors for the Treatment of B-Cell Lymphomas. Adv Hematol (2011) 0.85
The PTEN tumor suppressor gene and its role in lymphoma pathogenesis. Aging (Albany NY) (2015) 0.84
Mutational analysis of TP53, PTEN, PIK3CA and CTNNB1/beta-catenin genes in human herpesvirus 8-associated primary effusion lymphoma. Haematologica (2009) 0.83
Evaluation of AKT phosphorylation and PTEN loss and their correlation with the resistance of rituximab in DLBCL. Int J Clin Exp Pathol (2015) 0.78
Constitutive AKT activation in follicular lymphoma. BMC Cancer (2014) 0.78
PIK3CA expression in diffuse large B cell lymphoma tissue and the effect of its knockdown in vitro. Onco Targets Ther (2017) 0.75
PIK3CA amplification and PTEN loss in diffused large B-cell lymphoma. Oncotarget (2017) 0.75
Role of AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma. Am J Pathol (2017) 0.75
Protein kinase B/Akt mediates effects of insulin on hepatic insulin-like growth factor-binding protein-1 gene expression through a conserved insulin response sequence. J Biol Chem (1998) 1.70
Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population. Oncogene (2008) 1.46
Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to all-trans-retinoic acid. J Biol Chem (2000) 1.38
The p38 MAPK pathway mediates the growth inhibitory effects of interferon-alpha in BCR-ABL-expressing cells. J Biol Chem (2001) 1.33
Tyrosine phosphorylation of the alpha and beta subunits of the type I interferon receptor. Interferon-beta selectively induces tyrosine phosphorylation of an alpha subunit-associated protein. J Biol Chem (1994) 1.33
Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern. J Rheumatol (1998) 1.29
Interferon-alpha resistance in a cutaneous T-cell lymphoma cell line is associated with lack of STAT1 expression. Blood (1998) 1.28
Differences in interferon alpha and beta signaling. Interferon beta selectively induces the interaction of the alpha and betaL subunits of the type I interferon receptor. J Biol Chem (1996) 1.27
Protein kinase C-delta regulates thrombin-induced ICAM-1 gene expression in endothelial cells via activation of p38 mitogen-activated protein kinase. Mol Cell Biol (2001) 1.27
Engagement of Gab1 and Gab2 in erythropoietin signaling. J Biol Chem (1999) 1.17
The glyoxylate cycle in an arbuscular mycorrhizal fungus. Carbon flux and gene expression. Plant Physiol (2001) 1.15
Association of the interferon-dependent tyrosine kinase Tyk-2 with the hematopoietic cell phosphatase. J Biol Chem (1995) 1.15
Curcumin induces apoptosis via inhibition of PI3'-kinase/AKT pathway in acute T cell leukemias. Apoptosis (2006) 1.11
Concurrent methylation of multiple genes in childhood ALL: Correlation with phenotype and molecular subgroup. Leukemia (2003) 1.05
Rantes activates Jak2 and Jak3 to regulate engagement of multiple signaling pathways in T cells. J Biol Chem (2001) 1.04
RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population. J Endocrinol Invest (2008) 0.99
Focused echocardiography entry level: new concept of a 1-day training course. Minerva Anestesiol (2009) 0.97
Poxvirus infection rapidly activates tyrosine kinase signal transduction. J Biol Chem (2001) 0.96
Activation of a CrkL-stat5 signaling complex by type I interferons. J Biol Chem (1999) 0.94
The role of electrostatics in protein-protein interactions of a monoclonal antibody. Mol Pharm (2014) 0.92
ALK gene amplification is associated with poor prognosis in colorectal carcinoma. Br J Cancer (2013) 0.92
Epstein-Barr virus-associated leiomyosarcoma of the thyroid in a child with congenital immunodeficiency: a case report. Am J Surg Pathol (1999) 0.91
Herbal melanin modulates tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6) and vascular endothelial growth factor (VEGF) production. Phytomedicine (2005) 0.90
The type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2. J Biol Chem (1996) 0.90
FISH analysis in chromophobe renal-cell carcinoma. Diagn Cytopathol (2000) 0.88
Deviated nasal septum in the newborn-A 1-year study. Indian J Otolaryngol Head Neck Surg (2005) 0.88
Apigenin induces apoptosis via downregulation of S-phase kinase-associated protein 2-mediated induction of p27Kip1 in primary effusion lymphoma cells. Cell Prolif (2010) 0.87
Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy. J Pathol (2007) 0.87
Activation of the Jak-Stat pathway in cells that exhibit selective sensitivity to the antiviral effects of IFN-beta compared with IFN-alpha. J Interferon Cytokine Res (1999) 0.86
Betulinic acid reduces ultraviolet-C-induced DNA breakage in congenital melanocytic naeval cells: evidence for a potential role as a chemopreventive agent. Melanoma Res (2001) 0.85
IFN-gamma activates the C3G/Rap1 signaling pathway. J Immunol (2000) 0.85
Global action against multidrug-resistant tuberculosis. JAMA (2000) 0.85
S-phase kinase protein 2 is an attractive therapeutic target in a subset of diffuse large B-cell lymphoma. J Pathol (2008) 0.85
Prostaglandin E2 modulation of p59fyn tyrosine kinase in T lymphocytes during sepsis. J Immunol (1998) 0.84
A mixed Th1/Th2 cell cytokine response predominates in systemic onset juvenile rheumatoid arthritis: immunoregulatory IL-10 function. Clin Immunol Immunopathol (1998) 0.84
CrkL and CrkII participate in the generation of the growth inhibitory effects of interferons on primary hematopoietic progenitors. Exp Hematol (1999) 0.82
Novel and recurrent mutations in the AIRE gene of autoimmune polyendocrinopathy syndrome type 1 (APS1) patients. Clin Genet (2009) 0.82
The role of gonadectomy and testosterone replacement on thymic luteinizing hormone-releasing hormone production. J Endocrinol (1998) 0.81
Specific ion and buffer effects on protein-protein interactions of a monoclonal antibody. Mol Pharm (2014) 0.80
Phthalates in indoor dust in Kuwait: implications for non-dietary human exposure. Indoor Air (2012) 0.80
Jurkat cell proliferative activity is increased by luteinizing hormone-releasing hormone. J Endocrinol (1997) 0.80
Engagement of the CrkL adaptor in interferon alpha signalling in BCR-ABL-expressing cells. Br J Haematol (2001) 0.80
Sodium polystyrene sulfonate (kayexalate) aspiration: histologic appearance and infrared microspectrophotometric analysis of two cases. Arch Pathol Lab Med (1996) 0.80
Frequencies of the major subgroups of precursor B-cell acute lymphoblastic leukemia in Indian children differ from the West. Leukemia (2003) 0.79
In-situ hybridization as a molecular tool in cancer diagnosis and treatment. Curr Med Chem (2012) 0.79
Transforming growth factor alpha, beta 1 and beta 2 in breast cyst fluid. Anticancer Res (1995) 0.78
Incidence of rotaviral gastroenteritis at a referral centre in Saudi Arabia. Ann Saudi Med (1991) 0.78
Feedback on doctors' performance from parents and carers of children: a national pilot study. Arch Dis Child (2011) 0.78
Genetics of glucose-6-phosphate dehydrogenase deficiency in Saudi patients. Clin Genet (2010) 0.78
Defective expression of the SHP-1 phosphatase in polycythemia vera. Exp Hematol (1999) 0.78
Identification of a domain in the beta subunit of the type I interferon (IFN) receptor that exhibits a negative regulatory effect in the growth inhibitory action of type I IFNs. J Biol Chem (1998) 0.78
Chemo- and baroresponses differ in African-Americans and Caucasians in sleep. J Appl Physiol (1985) (1998) 0.78
Luteinizing hormone-releasing hormone (LHRH) in rat prostate: characterization of LHRH peptide, messenger ribonucleic acid expression, and molecular processing of LHRH in intact and castrated male rats. Endocrinology (1993) 0.77
All-trans-retinoic acid induces tyrosine phosphorylation of the CrkL adapter in acute promyelocytic leukemia cells. Exp Hematol (2000) 0.77
[3D-spectrogram of the doppler signal in real time]. Ultraschall Med (2000) 0.75
Double red cell concentrates -in vitro quality after delayed refrigeration. Transfus Med (2010) 0.75
Nitrous oxide production from soils amended with biogas residues and cattle slurry. J Environ Qual (2013) 0.75
Characteristics of predominantly nonwhite patients with frequent hospitalizations for acute asthma in Chicago. J Asthma (1997) 0.75
Parathyroid carcinoma: A report of two cases. Ann Saudi Med (2007) 0.75
Fine needle aspiration biopsy diagnosis of renal masses in children: A brief review. Ann Saudi Med (1994) 0.75
Concentrations of soluble vascular cell adhesion molecule-1 and E-selectin in breast cyst fluid and their relation with cyst type. Br J Surg (1995) 0.75
Primary hyperparathyroidism: a case report. Mymensingh Med J (2014) 0.75
Relationship between basic fibroblast growth factor and transforming growth factor-beta 2 in breast cyst fluid. J Clin Endocrinol Metab (1995) 0.75
The effects of ethanol on pituitary function. Compr Ther (1994) 0.75
Oncostatin M, interleukin 2, interleukin 6 and interleukin 8 in breast cyst fluid. Int J Cancer (1994) 0.75
A novel missense mutation in the HAX1 gene in severe congenital neutropenia patients (Kostmann disease). Clin Genet (2009) 0.75
An acetylated derivative of a new N-acylsphingosine from red alga Halymenia porphyroides. Planta Med (1990) 0.75
Induction and processing of promutagenic O4-ethylthymine lesion in specific gene segments of plasmid DNA. Biochim Biophys Acta (1995) 0.75
Activity of extracts of Kigelia pinnata against melanoma and renal carcinoma cell lines. Planta Med (1994) 0.75